Loading…

Therapeutic applications of ribozymes and riboswitches

Therapeutic approaches employing RNA as a tool or as a drug target have recently emerged and have been employed for various applications—ranging from cancer treatment to virus infection. Despite the paucity of its molecular groups compared to proteins, RNA has nevertheless proved to be an excellent...

Full description

Saved in:
Bibliographic Details
Published in:Current opinion in pharmacology 2010-10, Vol.10 (5), p.551-556
Main Authors: Mulhbacher, Jérôme, St-Pierre, Patrick, Lafontaine, Daniel A
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c476t-a911e23f879029e1e6b3b7450bd1d6223abbec98cea6f14381f0b324e58d32833
cites
container_end_page 556
container_issue 5
container_start_page 551
container_title Current opinion in pharmacology
container_volume 10
creator Mulhbacher, Jérôme
St-Pierre, Patrick
Lafontaine, Daniel A
description Therapeutic approaches employing RNA as a tool or as a drug target have recently emerged and have been employed for various applications—ranging from cancer treatment to virus infection. Despite the paucity of its molecular groups compared to proteins, RNA has nevertheless proved to be an excellent choice for researchers who have aspired to develop therapeutic tools. Ribozymes and riboswitches are RNA-based therapeutic tools that are most often employed to knockdown gene expression and to inhibit bacterial infections, respectively. The aim of this review is to summarize recent advances observed in ribozyme- and riboswitch-based therapeutic applications that, in some cases, have reached clinical trials.
doi_str_mv 10.1016/j.coph.2010.07.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_902363243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1471489210001086</els_id><sourcerecordid>902363243</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-a911e23f879029e1e6b3b7450bd1d6223abbec98cea6f14381f0b324e58d32833</originalsourceid><addsrcrecordid>eNp9kc1OwzAQhC0EoqXwAhxQb5xa1nbiJBJCQhV_UiUOlLPlOBvVJY2DnYDK0-PQlgMHTuu1Zkbabwg5pzClQMXVaqpts5wyCB-QTAHYARnSKKGTKEv44f6dZmxATrxfAdCY8-SYDBiINKYiHhKxWKJTDXat0WPVNJXRqjW29mNbjp3J7ddmjX6s6uJn85-m1Uv0p-SoVJXHs90ckdf7u8XscTJ_fnia3c4nOkpEO1EZpch4mSYZsAwpipznSRRDXtBCMMZVnqPOUo1KlDTiKS0h5yzCOC04SzkfkcttbuPse4e-lWvjNVaVqtF2XoZYLoKhV7KtUjvrvcNSNs6sldtICrLHJVeyxyV7XBISGXAF08UuvsvXWPxa9nyC4HorwHDkh0EnvTZYayyMQ93Kwpr_82_-2HVl6oC4esMN-pXtXB3wSSo9kyBf-sL6viiEriAV_Bu5gI_o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902363243</pqid></control><display><type>article</type><title>Therapeutic applications of ribozymes and riboswitches</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Mulhbacher, Jérôme ; St-Pierre, Patrick ; Lafontaine, Daniel A</creator><creatorcontrib>Mulhbacher, Jérôme ; St-Pierre, Patrick ; Lafontaine, Daniel A</creatorcontrib><description>Therapeutic approaches employing RNA as a tool or as a drug target have recently emerged and have been employed for various applications—ranging from cancer treatment to virus infection. Despite the paucity of its molecular groups compared to proteins, RNA has nevertheless proved to be an excellent choice for researchers who have aspired to develop therapeutic tools. Ribozymes and riboswitches are RNA-based therapeutic tools that are most often employed to knockdown gene expression and to inhibit bacterial infections, respectively. The aim of this review is to summarize recent advances observed in ribozyme- and riboswitch-based therapeutic applications that, in some cases, have reached clinical trials.</description><identifier>ISSN: 1471-4892</identifier><identifier>EISSN: 1471-4973</identifier><identifier>DOI: 10.1016/j.coph.2010.07.002</identifier><identifier>PMID: 20685165</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Gene Knockdown Techniques ; Genetic Therapy ; HIV Infections - genetics ; HIV Infections - therapy ; Humans ; Internal Medicine ; Medical Education ; Neoplasms - genetics ; Neoplasms - therapy ; Prion Diseases - genetics ; Prion Diseases - therapy ; Riboswitch - physiology ; RNA, Catalytic - genetics ; RNA, Catalytic - therapeutic use</subject><ispartof>Current opinion in pharmacology, 2010-10, Vol.10 (5), p.551-556</ispartof><rights>2010</rights><rights>Crown Copyright © 2010. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-a911e23f879029e1e6b3b7450bd1d6223abbec98cea6f14381f0b324e58d32833</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20685165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulhbacher, Jérôme</creatorcontrib><creatorcontrib>St-Pierre, Patrick</creatorcontrib><creatorcontrib>Lafontaine, Daniel A</creatorcontrib><title>Therapeutic applications of ribozymes and riboswitches</title><title>Current opinion in pharmacology</title><addtitle>Curr Opin Pharmacol</addtitle><description>Therapeutic approaches employing RNA as a tool or as a drug target have recently emerged and have been employed for various applications—ranging from cancer treatment to virus infection. Despite the paucity of its molecular groups compared to proteins, RNA has nevertheless proved to be an excellent choice for researchers who have aspired to develop therapeutic tools. Ribozymes and riboswitches are RNA-based therapeutic tools that are most often employed to knockdown gene expression and to inhibit bacterial infections, respectively. The aim of this review is to summarize recent advances observed in ribozyme- and riboswitch-based therapeutic applications that, in some cases, have reached clinical trials.</description><subject>Gene Knockdown Techniques</subject><subject>Genetic Therapy</subject><subject>HIV Infections - genetics</subject><subject>HIV Infections - therapy</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medical Education</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - therapy</subject><subject>Prion Diseases - genetics</subject><subject>Prion Diseases - therapy</subject><subject>Riboswitch - physiology</subject><subject>RNA, Catalytic - genetics</subject><subject>RNA, Catalytic - therapeutic use</subject><issn>1471-4892</issn><issn>1471-4973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kc1OwzAQhC0EoqXwAhxQb5xa1nbiJBJCQhV_UiUOlLPlOBvVJY2DnYDK0-PQlgMHTuu1Zkbabwg5pzClQMXVaqpts5wyCB-QTAHYARnSKKGTKEv44f6dZmxATrxfAdCY8-SYDBiINKYiHhKxWKJTDXat0WPVNJXRqjW29mNbjp3J7ddmjX6s6uJn85-m1Uv0p-SoVJXHs90ckdf7u8XscTJ_fnia3c4nOkpEO1EZpch4mSYZsAwpipznSRRDXtBCMMZVnqPOUo1KlDTiKS0h5yzCOC04SzkfkcttbuPse4e-lWvjNVaVqtF2XoZYLoKhV7KtUjvrvcNSNs6sldtICrLHJVeyxyV7XBISGXAF08UuvsvXWPxa9nyC4HorwHDkh0EnvTZYayyMQ93Kwpr_82_-2HVl6oC4esMN-pXtXB3wSSo9kyBf-sL6viiEriAV_Bu5gI_o</recordid><startdate>20101001</startdate><enddate>20101001</enddate><creator>Mulhbacher, Jérôme</creator><creator>St-Pierre, Patrick</creator><creator>Lafontaine, Daniel A</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20101001</creationdate><title>Therapeutic applications of ribozymes and riboswitches</title><author>Mulhbacher, Jérôme ; St-Pierre, Patrick ; Lafontaine, Daniel A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-a911e23f879029e1e6b3b7450bd1d6223abbec98cea6f14381f0b324e58d32833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Gene Knockdown Techniques</topic><topic>Genetic Therapy</topic><topic>HIV Infections - genetics</topic><topic>HIV Infections - therapy</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medical Education</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - therapy</topic><topic>Prion Diseases - genetics</topic><topic>Prion Diseases - therapy</topic><topic>Riboswitch - physiology</topic><topic>RNA, Catalytic - genetics</topic><topic>RNA, Catalytic - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulhbacher, Jérôme</creatorcontrib><creatorcontrib>St-Pierre, Patrick</creatorcontrib><creatorcontrib>Lafontaine, Daniel A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Current opinion in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulhbacher, Jérôme</au><au>St-Pierre, Patrick</au><au>Lafontaine, Daniel A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic applications of ribozymes and riboswitches</atitle><jtitle>Current opinion in pharmacology</jtitle><addtitle>Curr Opin Pharmacol</addtitle><date>2010-10-01</date><risdate>2010</risdate><volume>10</volume><issue>5</issue><spage>551</spage><epage>556</epage><pages>551-556</pages><issn>1471-4892</issn><eissn>1471-4973</eissn><abstract>Therapeutic approaches employing RNA as a tool or as a drug target have recently emerged and have been employed for various applications—ranging from cancer treatment to virus infection. Despite the paucity of its molecular groups compared to proteins, RNA has nevertheless proved to be an excellent choice for researchers who have aspired to develop therapeutic tools. Ribozymes and riboswitches are RNA-based therapeutic tools that are most often employed to knockdown gene expression and to inhibit bacterial infections, respectively. The aim of this review is to summarize recent advances observed in ribozyme- and riboswitch-based therapeutic applications that, in some cases, have reached clinical trials.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>20685165</pmid><doi>10.1016/j.coph.2010.07.002</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1471-4892
ispartof Current opinion in pharmacology, 2010-10, Vol.10 (5), p.551-556
issn 1471-4892
1471-4973
language eng
recordid cdi_proquest_miscellaneous_902363243
source ScienceDirect Freedom Collection 2022-2024
subjects Gene Knockdown Techniques
Genetic Therapy
HIV Infections - genetics
HIV Infections - therapy
Humans
Internal Medicine
Medical Education
Neoplasms - genetics
Neoplasms - therapy
Prion Diseases - genetics
Prion Diseases - therapy
Riboswitch - physiology
RNA, Catalytic - genetics
RNA, Catalytic - therapeutic use
title Therapeutic applications of ribozymes and riboswitches
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T04%3A04%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20applications%20of%20ribozymes%20and%20riboswitches&rft.jtitle=Current%20opinion%20in%20pharmacology&rft.au=Mulhbacher,%20J%C3%A9r%C3%B4me&rft.date=2010-10-01&rft.volume=10&rft.issue=5&rft.spage=551&rft.epage=556&rft.pages=551-556&rft.issn=1471-4892&rft.eissn=1471-4973&rft_id=info:doi/10.1016/j.coph.2010.07.002&rft_dat=%3Cproquest_cross%3E902363243%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c476t-a911e23f879029e1e6b3b7450bd1d6223abbec98cea6f14381f0b324e58d32833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=902363243&rft_id=info:pmid/20685165&rfr_iscdi=true